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ABSTRACT 
Defensins are an important component of the innate immune system of ticks. 
These small peptides are produced by various genera of tick, and expressed in 
various tissues. In this study we used RNA interference to silence the expression 
of the defensin varisin produced by the hemocytes of the American dog tick, 
Derrnacentor variabilis. Ticks were injected with double stranded varisin RNA . 
prior to being put on a rabbit. After feeding, the ticks were removed and bled. 
Hemolymph and hemocytes were separated and screened for the presence ( or 
absence) of both varisin transcript and peptide. Varisin peptide was below 
detectable levels and the transcript showed a greater than 99% knockdown. The 
antimicrobial activity of the hemolymph plasma was reduced 2 to 4 fold compared 
to that of control injected ticks indicating varisin accounts for a large portion of the 
antimicrobial activity of the hemolymph. 
INTRODUCTION 
Ticks are obligate blood-feeding ectoparasites that have the ability _to transmit a 
wide variety of disease causing microbes. In fact, they have the ability to 
transmit more disease causing microbes than any other blood feeding arthropod, 
including mosquitoes, although mosquitoes cause r:nore human illness than those 
caused by tick-borne agents. The hard tick Derrnacentor variabilis (American dog 
tick) can be found throughout the southeastern USA, and up the east coast to 
Nova Scotia (Brown 2005). This hard tick is a vector of the pathogens 
responsible for Rocky Mountain Spotted Fever (RMSF), human monocytotrophic 
ehrlichiosis (HME), tularemia, and is capable of causing tick paralysis. However,. 
ticks are more than 'syringes-on-legs'. Although lacking the highly developed, 
adaptive immune response found in vertebrates, ticks have an efficient innate 
immune response. The innate immune system consists of both cellular and 
soluble components (Gillespie et al. 1997; Schmid-Hempel 2005) that are 
effective in eliminating many microbes. The cellular responses include 
phagocytosis, nodulation, and encapsulation (Eggenberger et al. 1990; Inoue et 
al. 2001; Ceraul et al. 2002; Sonenshine and Hynes 2008). The soluble aspects 
of the innate immune response include production of antimicrobial peptides 
including defensins (Bulet et al. 2003; Sonenshine and Hynes 2008). 
Invertebrates produce many different types of antimicrobial molecules when 
challenged by microbes or parasites (Cociancich et al. 1994; Bulet et al. 2003; 
Tsuji et al. 2007; Sonenshine and Hynes 2008). Among the most conserved of 
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these molecules are the defensins. Defensins are small cationic peptides, 
generally 34-61 amino acids for the mature peptide (3-6k0a), produced by 
organisms from plants to invertebrates to the most complex mammals (Bulet et 
al. 2003; Sonenshine and Hynes 2008). Insect defensins generally hav~ six 
cysteine residues that form three disulfide bridges with linkages being Cys1-
Cys4? Cys2 .. Cys5, and Cys3-Cys6 (Bulet et al. 1999; Bulet et al. 2003); the 
exception being drosomycin, produced by Drosophilia melanogasterwhich has 
four disulfide bonds and antifungal activity (Michaut et al. 1996; Bulet et al. 
2003). To date more than 20 defensins have been identified from 11 species of 
tick (Sonenshine and Hynes 2008). Defensins are produced as a prepro form, 
which is cleaved to release the mature peptide at a highly conserved RVRR site 
'(Sonenshine and Hynes 2008). Some species of tick have multiple isoforms of 
defensin, with Omithodoros moubata having four isoforms (Nakajima et al. 2001; 
Nakajima et al. 2002) and /. ricinus having two isoforms (Rudenko et al. 2007), 
while others appear to have only one form (Hynes et al. 2005; Todd et al. 2007). 
The first defensin recognized from a hard tick was varisin, isolated from the 
hemolymph of American dog tick, Dermacentor variabilis (Johns et al. 2001 ). The 
transcript sequence of varisin was determined following RT-PCR from RNA 
isolated from hemocytes (Ceraul et al. 2003). It appears that varisin is produced 
in the hemocytes and released into the hemolymph following microbial challenge. 
Although transcript has been detected in various tissues (Ceraul 2005; 
Sonenshine et al. 2005; Ceraul et al. 2007) the peptide has only been detected in 
the hemolymph/hemocytes. Recently a second defensin has been reported from 
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D. variabilis which had less than 50% similarity to varisin (Ceraul et al. 2007). In 
order to understand the role of varisin in the innate immune system of D. 
variabilis, the expression of the varisin gene was silenced using RNA interference 
(RNAi). RNAi has been used to study gene function in ticks due to the lack of 
other means of genetic manipulation (de la Fuente et al. 2005; de la Fuente et al. 
2007). In this study we show that RNAi can be used to silence the gene for 
varisin and that silencing results in a decreased level of antimicrobial activity of 
tick hemolymph. 
MATERIALS AND METHODS 
Ticks, Injection, and Bleeding 
D. variabilis were from a colony maintained at Old Dominion University as 
previously described (Johns et al. 1998; Johns et al. 2001). All use of animals in 
this research was done in accordance with protocols approved by the Old 
Dominion University Institutional Animal Use and Ca~e Committee. Unfed virgin 
female ticks were injected with 1-5µ1 of double stranded RNA (dsRNA), or Shens 
solution for the controls, using a 30g x %" hypodermic needle attached to a 1 OµI 
Hamilton syringe. Injection was via the foramen between the capitulum and 
anterior end of the scutum. After injection, the needle was held in the tick's body 
for 30min to prevent leakage of the injected material. Subsequently, the ticks 
were confined within plastic capsules attached to New Zealand white Rabbits 
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(Oryctolagus cuniculus). After feeding for 5 days the ticks were forcibly removed 
from the rabbit and hemolymph was collected by severing the forelegs at the 
coxal-trochanteral joint and applying gentle pressure to the body. The clear 
amber-colored liquid expressed was collected in a glass micropipette and put into 
either 20µ1 Shen's saline solution (Oliver et al. 1974) or 100µ1 RNA later (Applied 
Biosystems, Foster City, CA) depending on the assay; Shens for protein and 
antimicrobial assays, RNA later for RT-PCR reactions. Approximately the s~me 
number of ticks were used for both control and test injections. 
Previous results have suggested storage of varisin in the hemocytes_ which is 
released on challenge (Ceraul et al. 2003). Stored varisin should be released on 
injection of the dsRNA. To show no new varisin was made and stored after 
injection of the dsRNA, some ticks were pin-pricked (wounded) and allowed to sit 
for 1h prior to bleeding. 
Double stranded RNA production 
· Double-stranded RNA was prepared from· a PCR product containing the entire 
624bp cDNA fragment of varisin derived from D. variabilis hemocytes using the 
MEGAscript RNAi kit (Applied Biosystems). The gene was first amplified from a 
plasmid (Ceraul et al. 2003) using the primers DEFT75: 5, -
TAA TACGACTCACTATAGGGTACTATGCGCGGACTTTGCATCTGC and 
DEFT733: 5, -
TAA TACGACTCACTA TAGGGTACTT ACGTCGACAAAGCGCTTCGG which 
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contain the T7 promoter for in vitro transcription ( shown in italics). Amplification 
was carried out using the following cycle parameters: 94°C for 2 minutes, 
followed by 35 cycles of 94°C for 30s and 68°C for 1min; 68°C for 7min 
completed the run. The PCR fragment was then used in the transcription reaction 
as described by t~e manufacturer. After transcr~ption, the reaction was treated to 
remove DNA and single stranded RNA, then purified, and ethanol precipitated. 
· The dsRNA was then resuspended in Shen's solution for injection into ticks. 
Control ticks were injected with the same volume of Shen's solution. Ticks were 
injected with 1011-1012 molecules of dsRNA as described above. 
Quantitative RT-PCR 
Using the "illustra QuickPrep Micro mRNA purification kit" (GE Healthcare, NJ) 
the mRNA was isolated from hemolymph collected in RNA-later. The isolated 
. mRNA was then treated with Turbo DNA-free (Applied Biosystems) to remove 
any residual DNA; this step was repeated if necessary. Reverse transcription 
reactions were carried out using the lmProm-11 Reverse Transcription System in 
the presence of RNasin according to the manufacturers instructions (Promega 
Corp, Madison, WI) using either Oligo(dT) or random hexamer primers. The 
synthesized cDNA was then used in real-time PCR reactions. Controls, in which 




Real-time PCR was carried out using the RT2 SYBR Green qPCR Master Mix 
(SuperArray Bioscience Corporation, Frederick, MD) on a Cepheid Smartcycler 
(Cepheid, Sunnyvale, CA). Control real-time reactions were set up monitoring 
actin expression using 0.2µM final concentration of actinF (5'-
GTACGCCAACACCGTTCTC-3') and actinR (5'-
ATCTTGATCTTCATGGTGGAA-3') primers. Reactions for the detection of 
varisin were 0.2µM defF (5'-CTTCGGATGCCCACTGAA-3') and defR (5'-
AGCAGGTGCAGGTCT-3'). The cDNA template (1µ1) was added last to the 25µ1 
reaction. All reactions were run on the same program: 95°C for 60s then 40 
cycles of 95°C for 15s, 60°C for 60s, and followed by a melt curve. CT values 
were determined and used either in the comparative CT method (LiLiCT) for 
relative quantification, or to determine the actual number of molecules based on 
a standard curve derived from adding known amounts of plasmid DNA to a set of 
real-time reactions. Controls without reverse transcriptase and without template 
were set up with each set of samples. 
Protein gels 
Hemolymph collected in Shen's solution was used to check for the presence or 
absence of the varisin band in both hemolymph plasma and hemocyte lysate. 
Hemocytes were collected from the hemolymph by centrifugation at 1000 x g for 
20 minutes at 4°C. The pellet was resuspended in 10µ1 water and frozen until 
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needed. ·cells were thawed and 4µ1 of the hemocytes were mixed with loading 
buffer and reducing agent, then heated at 70°C for 10 min before loading on a 4-
12% NuPAGE Tris-Bis SOS gel (lnvitrogen) with See Blue molecular weight 
marker (lmiitrogen). After electrophoresis at 200V for 35min, the gel was silver 
stained using the Silver Express staining kit (lnvitrogen). A western blot analysis 
of a similarly run gel was carried out as previously described (Ceraul et al. 2003) 
except that the primary antibody (anti-varisin) diluted 1 :50. 
Antimicrobial assay 
Antimicrobial activity of hemolymph plasma was assessed using a well diffusion 
assay. Samples (10µ1) to be tested were pipetted into 4mm diameter wells cut 
into a tryptic soy agar plates, then allowed to dry, exposed to chloroform vapors 
for 20 minutes, and aired. An overnight culture of Micrococcus luteus was 
seeded onto the su a~ of the plate using a sterile swab, and the plate incubated 
. at 37°C overnight. Zones of inhibition were seen as areas of no growth around 
the wells. Two fold dilution series were carried out using 0.9% saline as the 
diluent. The titer (arbitrary units, AU) was determined as the last dilution to show 




Screening of undiluted hemolymph plasma for antimicrobial activity against M. 
luteus indicated less activity in the dsRNA treated ti~k hemolymph, than in the 
ticks injected with Shen's solution (Figure 1 ). When the hemolymph was two-fold 
serially diluted, titers for the control (Shens injected) were 2-4 times higher than 
the test (dsRNA injected) sample. Control titers were 8-16 AU whereas the 
dsRNA injected tick_hemolymph was 4 AU. 
Loss of varisin peptide in hemolymph plasma and cells 
Cell lysate and hemolymph plasma were visualized on a polyacrylamide gel, 
stained for protein. As is shown in Figure 2a, the varisin peptide band is missing 
or very faint from the hemolymph of those ticks treated with dsRNA, while those 
treated with buffer still show the presence of a varisin-sized band. The same 
effect was seen with hemocyte extracts, in that the varisin band is present in the 
hemocytes of control ticks but not those injected with the dsRNA construct. 
Western blot analysis using the anti-varisin antibody confirmed the loss of the 
defensin in both hemolymph plasma (Figure 2b) and hemocytes (not shown). The 
presence of multiple bands in the western blot is most _lik~ly due to the non-
specific binding of antibodies to tick proteins as previously described (Ceraul et 
al. 2003). 
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To detect release of the varisin peptide following a wounding response, ticks 
were also wounded 1 h prior to bleeding and collecting the hemolymph. Figure 2 
shows that the wounding does not result in release of varisin from dsRNA treated 
ticks. No difference was seen in the presence or absence of the varisin band 
between non-wounded and wounded ticks. 
Real-time PCR assays 
Real-time PCR was used to determine the degree to which varisin transcription 
was silenced in treated ticks. Representative results are shown in Figure 3. 
Treatment with dsRNA results in a decrease in the amount of varisin transcript as 
seen by the number of cycles required for the transcript to be detected. Figure 3 
shows control and treated samples amplified using the varisin primers. The insert 
shows the graphs of control and treated reactions with the actin amplification; this . 
ensures equal amounts of template were added to the reaction. 
The effect of treatment can. easily be seen in this graph but to gain insight into 
how much the gene is silenced in <?Ur samples we determined the amou_nt of 
transcript remaining using both the relative quantification and standard curve 
methodologies. A standard curve was prepared in which the CT was plotted 
against the number of molecules present; we us~d ten-fold dilutions from 109 
through 103 copies of the varisin gene. Using the standard curve to determine 
the number of molecules of varisin, we found that injection of dsRNA for varisin 
resulted in a 99-99.5% knockdown. Using the MCT method for relative 
quantification treatment with dsRNA the knockdown was as high as 99.9%. 
These results show that injection of varisin dsRNA effectively silences the 
expression of the varisin gene. 
DISCUSSION 
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RNA interference is an effective way of examining gene function in ticks, and has 
been used to target a number of different genes (de la Fuente et al. 2007). We 
can now add to this list varisin, which we believe to be the major defensin in tick 
hemolymph. Inactivation of varisin results in a 2-4 fold reduction in the 
antimicrobial activity of tick hemolymph as determined by our plate assays. 
However, it does not account for all the inhibitory activity since hemolymph 
plasma from the treated ticks were still · able to inhibit the growth of Micrococcus 
luteus. What accounts for the other antimicrobial activity seen in the 
hemolymph? Perhaps the most likely candidate is lysozyme, which is known to 
be expressed by D. variabilis hemocytes (Simser et al. 2004; Ceraul et al. 2007) 
and possibly released into the hemolymph plasma fraction. We have previously 
shown that a lysozyme is able to enhance the antimicrobial activity of varisin 
(Johns et al. 2001). Whether authentic tick lysozyme functions with varisin in the 
same manner as the egg white lysozyme remains to be determined. What would 
happen to the antimicrobial titer of tick hemolymph if we silenced lysozyme 
expression as well as varisin? RNAi studies into this aspect are currently 
underway in our laboratory. 
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There are a number of other possible antimicrobial molecules that are present in 
tick hemolymph (Sonenshine and Hynes 2008) that could result in the effects 
seen here, i.e. only partial loss of the ability to inhibit ~acterial growth. One 
possible peptide that could be responsible for some activity would be the second 
defensin reported from D. variabilis, defensin-2 (Ceraul et al. 2007). However this 
is an unlikely player in the antimicrobial activity of hemolymph since it is 
expressed by the midgut and not ~xpressed by hemocytes. 
Defensins have been implicated as major players in the innate immune response 
of ticks. We have shown that RNAi can be used to target and silence varisin 
expression in hemocytes and therefore in hemolymph. We have previously 
. reported that varisin was most likely produced and stored in the hemocytes 
(Ceraul et al. 2003) then released into the hemolymph on wounding or following 
microbial challenge. New defensin would then be made at a later time (Ceraul 
2005). In this study, the initial challenge would be the injection of dsRNA into the 
hemocoel, resulting in release of the stored defensin. Varisin released at the time 
of dsRNA injection would be expected to have been lost from the tick within 24 h 
(Johns 2003). Since we do not detect any defensin in the hemocytes or 
released into the hemolymph, even after another wounding (Figure 2), it appears 
that RNAi effectively prevents synthesis of new varisin. What effect this has on 
the tick, beyond any role in the innate immune response, is unknown since 
defensin has been suggested to have an alternative function in mosquito 
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immunity (Bartholomay et al. 2004). What, if any, additional or alternative roles 
varisin has in tick immunity requires further investigation, as is the .actual in vivo 
effect of varisin silencing. 
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Figure legends: 
Figure 1. Antimicrobial activity of hemolymph against Micrococcus luteus from 
control (a) and treated (b) ticks. The same volume of hemolymph was added to 
each well. The lower well was buffer control. Hemolymph used in this assay was 
from 2 separate injections of varisin dsRNA 
Figure 2. PAGE (a) and Western blot (b) showing inhibition of defensin 
production by vsn dsRNA. MW is molecular weight markers. Lanes 1 and 2 are 
those injected with Shen's, lanes 3 and 4 are ticks injected with dsRNA. Lanes 1 
and 3 are samples in which the tick was bled after removal from the rabbit, 2 and 
4 are samples obtained 1 h after the ticks were wounded. The arrow indicates the 
varisin band. 
Figure 3. Real time PCR results following amplification of cDNA derived from 
control and treated ( dsRNA) tick hemocytes. The insert shows the same graph 
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